ArticleTherapeutic innovation & regulatory science2022

A Composite Endpoint for Acceptability Evaluation of Oral Drug Formulations in the Pediatric Population.

Manfred Wargenau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.